NYSE:MDT

Medtronic Stock Insider Trading

Healthcare > Medical - Devices

Buy MDT

*Your capital is at risk

$85.39

-0.320 (-0.373%)

At Close: Jul 31, 2026

Medtronic Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -28.15. In total, the insiders bought 577.03M and sold 181.58K MDT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-28.15
● Buy	577.03M shares
● Sell	181.58K shares
54% Buy Activity Negligible or No Correlation
Buy Signal Low Confidence May 26, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -28.15. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 03, 2025 Sell	Ordinary Shares S-Sale	Kiil Harry Skip EVP & President Cardiovascular	CEO / President	200 Value: $18.3K
Sep 03, 2025 Sell	Ordinary Shares S-Sale	Kiil Harry Skip EVP & President Cardiovascular	CEO / President	8 405 Value: $769.7K
Aug 25, 2025 Buy	Ordinary Shares P-Purchase	Jellison William R Director	Director	2 500 Value: $230.9K
Aug 25, 2025 Buy	Ordinary Shares P-Purchase	Jellison William R Director	Director	2 500 Value: $230.9K
Aug 22, 2025 Buy	Ordinary Shares P-Purchase	Jellison William R Director	Director	2 500 Value: $231.8K
Aug 22, 2025 Buy	Ordinary Shares P-Purchase	Jellison William R Director	Director	2 500 Value: $231.8K
Aug 20, 2025 Sell	Ordinary Shares F-InKind	Marinaro Michael EVP, Pres Medsurg And Americas	Officer	1 052 Value: $98.1K
Aug 20, 2025 Sell	Ordinary Shares F-InKind	Marinaro Michael EVP, Pres Medsurg And Americas	Officer	1 052 Value: $98.1K
Aug 19, 2025 Buy	Ordinary Shares	Jellison William R Director	Director	0 Value: $0
Aug 19, 2025 Buy	Ordinary Shares	Groetelaars John P Director	Director	0 Value: $0
Aug 19, 2025 Buy	Ordinary Shares	Groetelaars John P Director	Director	0 Value: $0
Aug 19, 2025 Buy	Ordinary Shares	Jellison William R Director	Director	0 Value: $0
Aug 01, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Walter Matthew R. SVP, Chief Hr Officer	Officer	963 Value: $75.1K
Aug 01, 2025 Buy	Performance Share Unit M-Exempt	Walter Matthew R. SVP, Chief Hr Officer	Officer	2 179 Value: $194.7K
Aug 01, 2025 Sell	Ordinary Shares F-InKind	Walter Matthew R. SVP, Chief Hr Officer	Officer	364 Value: $32.5K
Jul 29, 2025 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	1 540 Value: $123.2K
Jul 31, 2024 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	25 408 Value: $2.23M
Aug 01, 2023 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	26 890 Value: $2.50M
Aug 02, 2022 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	6 358 Value: $834.6K
Aug 03, 2021 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	10 181 Value: $990.9K
Jul 29, 2020 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	1 615 Value: $166.8K
Jul 30, 2019 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	6 271 Value: $558.6K
Jul 31, 2018 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	4 407 Value: $370.1K
Jan 30, 2018 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	1 608 Value: $120.1K
Aug 01, 2017 Buy	Stock Option (Right to Buy)	Thompson Kweli EVP & President, Neuroscience	CEO / President	1 704 Value: $150.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MEDTRONIC PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides ...

Read Full Profile Here